With over 30 years of experience, Keith Newburry is the founder of Newburry Strategic Advisory, specializing in global IP and litigation strategy for law firms, corporations, and investors, with a particular focus on IP due diligence in the medical device sector. Keith has led more than 100 patent, trade secret, trademark infringement, and validity trials worldwide, including global patent enforcement efforts that have resulted in recoveries exceeding $3 billion.
Keith’s leadership roles span notable organizations such as Edwards Lifesciences, Avery Dennison, Honeywell International, and Sheppard Mullin. He has served as a corporate board member, advised corporate boards, audit committees, C-suite executives, and handled high-stakes matters involving the U.S. Department of Justice.
A dedicated mentor, Keith has guided the professional growth of over 100 attorneys and legal staff throughout his career. He has also transformed and modernized the IP organizations of two S&P 500 companies, conducting comprehensive legal software assessments and implementations with a focus on real-world user needs and operational excellence.